IDiyas

For the Inventor, By the Inventor

Bethesda, MD, United States of America

Northwest Biotherapeutics, Inc.


USPTO Granted Patents = 16



Trademarks = 5

Forward Citations = 130

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Alton L Boynton (9 out of 17 patents)

silverMedal Marnix L Bosch (8 out of 8 patents)

bronzeMedal Gerald P Murphy (5 out of 18 patents)

4.  Anil Sehgal (5 out of 6 patents)

5.  Benjamin A Tjoa (4 out of 5 patents)

6.  Patricia A Lodge (3 out of 3 patents)

7.  Paul C Harris (2 out of 15 patents)

8.  Eric H Holmes (2 out of 19 patents)

9.  Steven J Monahan (2 out of 2 patents)

10.  Allen Turner (2 out of 2 patents)

11.  Julie A McEarchern (1 out of 12 patents)

12.  William T Tino (1 out of 17 patents)

13.  Paul G Hugenholtz (1 out of 1 patent)

14.  Yaling Zhou (1 out of 1 patent)

15.  Anne L Sherwood (1 out of 3 patents)


16 patents:

1. 11827903 - Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines (2023-11-28),
2. 11124768 - Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response (2021-09-21),
3. 10731130 - Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines (2020-08-04),
4. 9566294 - Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis (2017-02-14),
5. 9102917 - Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines (2015-08-11),
6. 8518636 - Tangential flow filtration devices and methods for leukocyte enrichment (2013-08-27),
7. 8409566 - Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis (2013-04-02),
8. 8389278 - Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines (2013-03-05),
9. 7790039 - Tangential flow filtration devices and methods for stem cell enrichment (2010-09-07),
10. 7695627 - Tangential flow filtration devices and methods for leukocyte enrichment (2010-04-13),
11. 7087715 - Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses (2006-08-08),
12. 6936448 - Nucleic acids and proteins of a rat ganglioside GM1-specific α1-2fucosyltransferase and uses thereof (2005-08-30),
13. 6863887 - Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis (2005-03-08),
14. 6150508 - Monoclonal antibodies specific for the extracellular domain of (2000-11-21),
15. 5990294 - Nucleotide and amino acid sequences of C4-2, a tumor suppressor gene, (1999-11-23),
Northwest Biotherapeutics, Inc. is a biotechnology company focused on developing personalized immunotherapy products for treating cancers. They specialize in DCVax, a platform technology using patient-specific dendritic cells to activate the immune system against tumor cells. With years of research and clinical trials, Northwest Biotherapeutics aims to provide innovative and effective cancer treatments to improve patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
16 Patents

#23 in Bethesda, MD

#265 in Maryland

#19,264 in US

#36,617 in the World

...
Bethesda, MD, United States of America

Northwest Biotherapeutics, Inc.

Forward Citations = 130

32 inventors:

goldMedal Alton L Boynton (9 out of 17 patents)

silverMedal Marnix L Bosch (8 out of 8 patents)

bronzeMedal Gerald P Murphy (5 out of 18 patents)

4.  Anil Sehgal (5 out of 6 patents)

5.  Benjamin A Tjoa (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…